C21 (1 mg/kg/d PO) for 20 weeks post-STZ; Reduced glomerulosclerosis, mesangial expansion, albuminuria; inhibited many markers of oxidative stress, inflammation, and fibrosis; increased MMP2/9. This evidence concerns the gene MMP2 and glomerulosclerosis.